Niemann Pick Disease Type C — Patent Landscape

Aggregated US Orange Book patent estate across every approved drug for niemann pick disease type c. 10 active patents protecting 1 drugs from 1+ originators. First major cliff: 2033. Daily refresh.

1
Approved drugs
10
Active US patents
72/100
Avg vulnerability
—
Annual revenue covered

Originators in Niemann Pick Disease Type C

Companies holding active patents on drugs approved for this indication. Click through to each company's full patent dashboard.

AstraZeneca 10 patents

Cliff calendar — next 15 years

Patent expiries per year across all drugs treating niemann pick disease type c. Each bar = one year. Y-axis scaled to peak year (3 patents).

3
33
3
35
2
36
1
37
1
38

Approved drugs ranked by patent estate

Drug Originator Active patents Avg vuln Revenue First cliff
Zavesca
MIGLUSTAT
 AstraZeneca 10 72 — 2033-03-07

Most attackable patents

Highest vulnerability scores in the indication — paragraph IV / IPR / design-around candidates.

Patent Drug Type Vuln Expiry
12419937 Zavesca method of use 75 2033-03-07
12414985 Zavesca method of use 75 2036-12-29
12246062 Zavesca method of use 75 2038-09-16
11278599 Zavesca method of use 70 2033-03-07
10512677 Zavesca method of use 70 2033-03-07
10208299 Zavesca method of use 70 2035-09-30
11753632 Zavesca method of use 70 2035-09-30
10961522 Zavesca method of use 70 2035-09-30
11278601 Zavesca method of use 70 2036-12-29
10857212 Zavesca method of use 70 2037-08-12

Strongest defences

Lowest vulnerability scores — pillars of the indication's IP fortress.

Patent Drug Type Vuln Expiry
10857212 Zavesca method of use 70 2037-08-12
11278601 Zavesca method of use 70 2036-12-29
10208299 Zavesca method of use 70 2035-09-30
10961522 Zavesca method of use 70 2035-09-30
11753632 Zavesca method of use 70 2035-09-30
10512677 Zavesca method of use 70 2033-03-07
11278599 Zavesca method of use 70 2033-03-07
12246062 Zavesca method of use 75 2038-09-16
12414985 Zavesca method of use 75 2036-12-29
12419937 Zavesca method of use 75 2033-03-07

Related